Skip Navigation
Search Menu
Find an Expert


Photo of Dr. David Valle

David Lee Valle, M.D.

Director, Institute of Genetic Medicine
Professor of Pediatrics


Appointment Phone


Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Director, Institute of Genetic Medicine
  • Henry J. Knott Professor
  • Professor of Pediatrics
  • Joint Appointment in Medicine
  • Joint Appointment in Molecular Biology and Genetics
  • Professor of Ophthalmology

Centers & Institutes



The Johns Hopkins Hospital

Appointment Phone: 410-955-3071

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-955-4260

Contact for Research Inquiries

Johns Hopkins University School of Medicine

Institute of Genetic Medicine
733 N Broadway
Baltimore, MD 21287 map
Phone: 410-955-4260


Medical Genetics

Research Interests

Clinical, biochemical, and molecular bases of disease; Genetic factors in neuropsychiatric disease; Inborn errors of metabolism; Medical sequencing, genome sequencing and comparative genomics


Dr. David Valle is the director of the Institute of Genetic Medicine and professor of pediatrics and ophthalmology at the Johns Hopkins School of Medicine. He also serves as a geneticist for the Johns Hopkins Children’s Center and is board-certified by the American Board of Medical Genetics in clinical molecular genetics, clinical biochemical genetics, clinical genetics and pediatrics.

Dr. Valle holds a bachelor’s degree and medical degree from Duke University. He completed a pediatric residency at Johns Hopkins University before joining the Johns Hopkins faculty. 

He is interested in the genetic contributions to health and disease. He is the founding director of the Johns Hopkins Center for Inherited Disease Research. Over the years, his laboratory has discovered the genetic causation for more than 20 diseases, including those responsible for inborn errors of metabolism, inherited retinal degeneration, disorders of cellular organelle biogenesis and genetic variations that contribute risk for common disorders such as schizophrenia.

Dr. Valle also serves as director of the Predoctoral Training Program in Human Genetics, as well as co-director of the Genes to Society program. He was a 2014 recipient of the annual Victor A. McKusick Leadership Award from the American Society of Human Genetics, which recognizes individuals whose professional achievements have fostered and enriched the development of human genetics as well as its assimilation into the broader context of science, medicine and health. more

Featured Video

Part I, Training the Next Generation of Physicians

More Videos

    Additional Information

  • Education +


    • Duke University School of Medicine / MD (1969)


    • Johns Hopkins University School of Medicine / Pediatrics (1971)
    • Johns Hopkins University School of Medicine / Pediatrics (1975)


    • American Board of Medical Genetics / Clinical Biochemical Genetics (1982)
    • American Board of Medical Genetics / Clinical Genetics / MD (1982)
    • American Board of Medical Genetics / Clinical Molecular Genetics (1993, 2010)
    • American Board of Pediatrics / Pediatrics (1978)
  • Research & Publications +

    Research Summary

    In the broadest sense, my research interests include understanding all aspects of the role of genetic factors in human health and disease. In particular, our studies involve clinical, biochemical, molecular and therapeutic aspects of specific human genetic diseases as well as more global studies of the network interactions and consequences of the genes and proteins implicated in human disease.

    In the past, our lab has focused primarily on rare monogenic disorders including inborn errors of amino acid metabolism as well as various human retinal degenerations. For example, we have conducted extensive molecular, biochemical and structural studies of the enzymes of proline and ornithine metabolism defining the biochemical and molecular bases of several. Most notably, we showed that deficiency of ornithine-delta-aminotransferase (OAT) causes a blinding, chorioretinal degeneration known as gyrate atrophy of the choroid and retina (GA). We also produced a knockout mouse deficient in OAT, showed that it develops a retinal degeneration and used this model to develop and validate treatments. Similarly, we are interested in inborn errors of biogenesis and function of the peroxisome, a ubiquitous sub-cellular organelle whose protein components participate in numerous metabolic pathways. Using a variety of strategies, we identified the genes responsible for several (>10) genetic disorders of peroxisomal biogenesis (e.g. Zellweger syndrome). We also have a special interest in peroxisomal ABC transporters and have produced knockout mice for the genes encoding some of these to elucidate the function of these transporters and their role in human genetic disease.

    Recently, we have focused most of our efforts on understanding the genetic contribution to neuropsychiatric disease, especially schizophrenia. Working together with our collaborators Ann Pulver, Dimitri Avramopoulos and Gerry Nestadt, we have utilized a variety of whole genome approaches to search for genetic variants contributing risk for these disorders. Currently we are performing extensive studies of the genes in 10q22-23 and 8p21; we have found both linkage and association evidence for one or more schizophrenia susceptibility genes in both these regions. Our studies include extensive high throughput genotyping and sequencing, functional evaluation of coding variants and variants in candidate regulatory sequences and development and characterization of mouse models for the strongest candidates. The overall all goals of these studies are to identify the genes and the causative variants contributing risk and to use this information to identify key biological systems involved in the causation and pathophysiology of these disorders. We will use this information to search for additional risk genes and environmental variables as well as for the rational development of therapies.

    Selected Publications View all on PubMed

    Mejias R, Adamczyk A, Anggono V, Niranjan T, Thomas GM, Sharma K, Skinner C, Schwartz CE, Stevenson RE, Fallin MD, Kaufmann W, Pletnikov M, Valle D, Huganir RL, Wang T. "Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism." Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4920-5.

    Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, Cutler DJ, Pulver AE, Warren ST. "Microdeletions of 3q29 confer high risk for schizophrenia." Am J Hum Genet. 2010 Aug 13;87(2):229-36.

    Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, Stevens EL, Ge D, Shianna KV, Smith JP, Maia JM, Gumbs CE, Pevsner J, Thomas G, Valle D, Hoover-Fong JE, Goldstein DB. "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene." PLoS Genet. 2010 Jun 17;6(6):e1000991.

    Chen PL, Avramopoulos D, Lasseter VK, McGrath JA, Fallin MD, Liang KY, Nestadt G, Feng N, Steel G, Cutting AS, Wolyniec P, Pulver AE, Valle D. "Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia." Am J Hum Genet. 2009 Jan;84(1):21-34. doi: 10.1016/j.ajhg.2008.12.005.

    Willis A, Bender HU, Steel G, Valle D. "PRODH variants and risk for schizophrenia." Amino Acids. 2008 Nov;35(4):673-9. doi: 10.1007/s00726-008-0111-0. Epub 2008 Jun 5.

    Han L, Witmer PD, Casey E, Valle D, Sukumar S. "DNA methylation regulates MicroRNA expression." Cancer Biol Ther. 2007 Aug;6(8):1284-8. Epub 2007 May 24.

    Zhang L, Jie C, Obie C, Abidi F, Schwartz CE, Stevenson RE, Valle D, Wang T. "X chromosome cDNA microarray screening identifies a functional PLP2 promoter polymorphism enriched inpatients with X-linked mental retardation." Genome Res. 2007 May;17(5):641-8. Epub 2007 Apr 6.

  • Academic Affiliations & Courses +

    Courses and Syllabi

    Molecules and Cells
    1st year medical school

    Human Genetics
    1st year graduate school

  • Activities & Honors +


    • Elected, Association of American Physicians
    • Victor A. McKusick Leadership Award, American Society of Human Genetics, 2014


    • American Association for the Advancement of Science
    • American College of Medical Genetics 
    • American Federation for Clinical Research
    • American Pediatrics Society
    • American Society of Clinical Investigation 
    • American Society of Human Genetics 
      Past president
    • European Society of Human Genetics 
    • Genetics Society of America
    • Human Genome Organization 
    • Institute of Medicine of the National Academy of Sciences
    • Society for Inherited Metabolic Disorders 
    • Society for Pediatric Research 
    • Society for the Study of Inborn Errors of Metabolism 

    Professional Activities

    • Member, Large Scale Sequencing Committee, National Human Genome Research Institute
    • Member, Large Scale Sequencing Advisory Committee, National Human Genome Research Institute
    • Past president, American Society of Human Genetics
  • Videos & Media +


    Part II, Training the Next Generation of Physicians

    Part III, Training the Next Generation of Physicians

    Part IV, Training the Next Generation of Physicians

Is This You? Edit Profile